Trump’s HHS proposed Thursday afternoon to drop the current way that Medicare covers drugs under Part B — calculating the average sales price and adding 6% to the providers who manage the drug supply — and switch to a new system that pegs US prices against the mush lower rates that have been established by single-payer systems abroad.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,